BusinessNewswireStartupsTechnology

Navigating Regulation to Build Venture-Backable Companies

Originally published on: December 20, 2025
▼ Summary

– Building a startup in regulated industries presents significant challenges, including elongated timelines that require careful planning from the start.
– Enspectra Health’s CEO, Gabriel Sanchez, detailed his decade-long journey to FDA clearance for a device that aims to replace dermatologist skin biopsies.
– Sanchez provided tactical advice on navigating long regulatory processes and keeping a company afloat and motivated during uncertainty.
– Earth Funeral, an end-of-life startup, faces legislative rather than FDA hurdles, as its process of transforming remains into soil requires legalization state-by-state.
– The company’s expansion depends on convincing legislative bodies and voters, who may be uncomfortable with this new burial method, to change laws.

Building a successful startup is difficult enough, but launching a company within a heavily regulated industry introduces a formidable layer of complexity. Navigating government agencies and legislative frameworks demands immense patience, capital, and strategic foresight from the very beginning. This week’s episode of Build Mode features founders who are tackling these exact challenges, proving that transformative innovation can thrive even under strict oversight.

Host Isabelle Johannessen first speaks with Gabriel Sanchez, CEO and co-founder of Enspectra Health. His company developed a non-invasive device designed to replace the need for traditional skin biopsies. Sanchez details the arduous, decade-long path to securing FDA clearance, a journey that tested every aspect of his resilience and business acumen. He shares practical strategies for surviving prolonged regulatory reviews, including how to maintain company morale and secure funding during periods of extreme uncertainty. His experience underscores a critical point: securing regulatory approval is not a side project but a core company objective that must be planned and resourced accordingly.

The conversation then shifts to Tom Harries, co-founder of Earth Funeral. His company offers an alternative to traditional burial and cremation by converting human remains into soil. While this process did not require FDA approval, it presented a different kind of regulatory hurdle: legalization. Earth Funeral launched when its method was only permitted in a single state. Harries’s path to scaling the business depends entirely on changing state laws and shifting public perception, a grassroots legislative effort far removed from a clinical trial. His story highlights that regulation isn’t confined to federal agencies; it can also involve convincing lawmakers and communities to embrace new ideas.

Both founders emphasize that regulatory challenges, whether scientific or societal, fundamentally extend timelines and increase costs. They require founders to build not just a product, but a compelling case for its safety, efficacy, and social acceptance. Success hinges on meticulous planning, transparent communication with stakeholders, and an unwavering long-term vision. The episode makes it clear that in regulated spaces, the ability to manage these external processes is as vital as the underlying technology itself.

New episodes of Build Mode are released every Thursday. You can subscribe to the podcast on major platforms or watch the interviews on YouTube. The show is hosted by Isabelle Johannessen, produced and edited by Maggie Nye, with audience development led by Morgan Little. Special thanks go to the Foundry and Cheddar video production teams.

(Source: TechCrunch)

Topics

regulated industries 95% innovation hurdles 90% startup challenges 85% regulatory planning 85% Industry Disruption 80% fda clearance 80% end-of-life services 80% podcast episode 75% legislative challenges 75% founder advice 75%